Results of their phase 2a trial of Eylea +/- OPT-302 for DME is expected in 2Q 2020.
If history is any guide, we will get results much sooner than expected.
Results of their phase 2a trial of Eylea +/- OPT-302 for DME is...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.8¢ |
Change
-0.028(4.87%) |
Mkt cap ! $667.8M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.0¢ | 53.0¢ | $312.8K | 574.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 83999 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 20788 | 9 |
View Market Depth
| Last trade - 13.00pm 04/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |